Cargando…

Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma

The molecular differences in genetic and epigenetic profiling between early-stage (ES) and late-stage (LS) lung adenocarcinoma (LUAD), which might help to understand cancer progression and biomarker guided precision treatment, need further be investigated. In this study, we performed comprehensive a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Dongsheng, Liu, Weiran, Gao, Liuwei, Zhang, Lianmin, Wang, Tao, Xiao, Shanshan, Fu, Yingxue, Li, Nan, Lin, Rui, Hu, Yao, Ding, Lieming, Zhang, Zhenfa, Zhang, Bin, Wang, Changli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567144/ https://www.ncbi.nlm.nih.gov/pubmed/34745971 http://dx.doi.org/10.3389/fonc.2021.746943

Ejemplares similares

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma
por: Huo, Yansong, et al.
Publicado: (2022)

Ion channel gene GJB2 influences the intercellular communication by Up-regulating the SPP1 signaling pathway identified by the single-cell RNA sequencing in lung adenocarcinoma
por: Liu, Zuo, et al.
Publicado: (2023)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012)

Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Hua, et al.
Publicado: (2016)

Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer
por: Gao, Liuwei, et al.
Publicado: (2017)

CITED4 enhances the metastatic potential of lung adenocarcinoma
por: Zhang, Lianmin, et al.
Publicado: (2021)

Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure
por: Dai, Shun-Dong, et al.
Publicado: (2021)

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm
por: Zhang, Hua, et al.
Publicado: (2021)

The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non‐small cell lung cancer after surgery
por: Zhang, Lianmin, et al.
Publicado: (2019)

Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis
por: Zhang, Bin, et al.
Publicado: (2020)

A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system
por: Gao, Zhaoming, et al.
Publicado: (2022)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
por: Liu, Wei, et al.
Publicado: (2023)

Editorial: Application and innovation of multiomics technologies in clinical oncology
por: Li, Xinmin, et al.
Publicado: (2023)

The role of physics in multiomics and cancer evolution
por: Gourmet, Lucie E., et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
por: Zhang, Mengzhe, et al.
Publicado: (2023)

Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center
por: Zhu, Jianquan, et al.
Publicado: (2021)

Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer
por: Wang, Shengguang, et al.
Publicado: (2017)

Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
por: Liu, Weiran, et al.
Publicado: (2016)

lncRNA-u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling
por: Wei, Wei, et al.
Publicado: (2019)

Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis
por: Li, Fu, et al.
Publicado: (2022)

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Persistence of smoking induced non‐small cell lung carcinogenesis by decreasing ERBB pathway‐related microRNA expression
por: Zhang, Lianmin, et al.
Publicado: (2019)

The Value of CT-Based Radiomics for Predicting Spread Through Air Spaces in Stage IA Lung Adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2022)

Pulmonary metastasis of stage I, low-grade endometrioid carcinoma: two case reports and the literature review
por: Wang, Li, et al.
Publicado: (2023)

CT‐based radiomics model to predict spread through air space in resectable lung cancer
por: Gong, Jialin, et al.
Publicado: (2023)

Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation
por: Zhang, Lianmin, et al.
Publicado: (2017)

Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study
por: Han, Jianglong, et al.
Publicado: (2020)

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
por: Wang, Gang, et al.
Publicado: (2023)

Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity
por: Li, Yue, et al.
Publicado: (2021)

Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients
por: Liang, Naixin, et al.
Publicado: (2021)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component
por: Li, Peng, et al.
Publicado: (2022)

Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study
por: Qiu, Guanghao, et al.
Publicado: (2021)

Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
por: Sun, Xiaoyan, et al.
Publicado: (2022)

Mediastinal lymph node dissection versus spared mediastinal lymph node dissection in stage IA non-small cell lung cancer presented as ground glass nodules: study protocol of a phase III, randomised, multicentre trial (MELDSIG) in China
por: Li, Chenguang, et al.
Publicado: (2023)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
por: Zhao, Zihuan, et al.
Publicado: (2020)

Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma
por: Zhang, Jinzhong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e77qk62vuga50visshjbnn4764